Humalog

Humalog is a prescription medication approved to treat type 1 and type 2 diabetes. The insulin, which is injected within 15 minutes before or after meals, is designed to help control the blood sugar spike that occurs after meals. Potential side effects of Humalog include low blood sugar, skin reaction at the injection site, and thickening or pitting of the skin at the injection site.

What Is Humalog?

Humalog® (insulin lispro) is a prescription form of insulin used to treat type 1 and type 2 diabetes. It is a rapid-acting insulin, used to help control the spike in blood sugar that occurs after meals. It is typically used in combination with a long-acting insulin. The medication can also be used in an insulin pump.
 
This article refers to plain Humalog. Humalog is also available in combination with an intermediate-acting insulin (Humalog Mix75/25® and Humalog Mix50/50®).
 
(Click Humalog Uses for more information, including possible off-label uses.)
 

Who Makes It?

Humalog is manufactured by Eli Lilly and Company.
 

Effects of Humalog

Studies have shown that Humalog worked as well as regular human insulin.
 People with type 1 diabetes taking the drug may have a lower chance of nighttime hypoglycemia (low blood sugar), compared to those taking regular human insulin.
 
Humalog Article Continues on Next Page >
Other Articles in This eMedTV Presentation